Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery
ConditionEpilepsy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorKayela Arrotta
About this trial
The goal of this clinical trial is to learn if new educational program prior to epilepsy surgery can either decrease the risk of cognitive decline after surgery or be a help to those patients who experience a decline after undergoing epilepsy surgery.
Participants will participate in 2 individual virtual sessions and 4 virtual group sessions over the course of 5-6 weeks prior to their epilepsy surgery. They will asked to fill out online surveys and questionnaires at various times throughout the study, up to 12 months after their surgery.
To see if the educational program works, researchers will compare those participating in the educational program with those that are receiving the standard epilepsy care prior to surgery.
Eligibility criteria
Qualifiers
Adults, aged 18-60 years old, with diagnosed epilepsy who have been confirmed as an appropriate surgical candidate by their epileptologist
Able to independently provide informed consent
Fluent in English
Reading abilities at or above 8th grade level as determined by the Wide Range Achievement Test- 4th Edition (WRAT-4), Reading subtest.
Disqualifiers
Any patient that has engaged in any form of cognitive rehabilitation/intervention within the last 6 months
Ongoing litigation related to the cause of epilepsy, unless litigation is related to short term or long-term disability application.
Undergoing intensive medical treatment for serious or life-threatening illness (e.g., chemotherapy, etc.) that would impact study participation.
Serious psychiatric condition that could interfere with participation, such as schizophrenia, active psychosis, active mania, and current suicidal ideation.
Trial design
Treatments tested in this trial
- ReBOOT program
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Kayela Arrotta
Lead sponsor
The Cleveland Clinic
Sponsor institution
American Psychological Association (APA)
Collaborator
American Epilepsy Society
Collaborator
The Cleveland Clinic
Collaborator
Source ClinicalTrials.gov